BioSpace News Archive

Genetown

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco on Thursday, January 11, 2024, at 9:45 a.m. PT (12:45 p.m. ET).

January 2, 2024
·
1 min read
BioMidwest

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation, a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20 million.

January 2, 2024
·
6 min read
Drug Development

Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics Inc. (Nasdaq: RGLS), today announced it has completed enrollment in the third cohort of patients in the Phase 1b MAD study of RGLS8429 for the treatment of ADPKD.

January 2, 2024
·
5 min read
Genetown

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 02, 2024

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company granted 42,000 restricted stock units to one newly-hired employee.

January 2, 2024
·
2 min read
Pharm Country

Rocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) today announced that Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, at 3:45 p.m. PT.

January 2, 2024
·
4 min read
Biotech Bay

Exelixis to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024

Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 4:30 p.m. PT / 7:30 p.m. ET.

January 2, 2024
·
1 min read
BioMidwest

SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split - Jan 02, 2024

SAB Biotherapeutics, Inc. announced that it will effect a reverse stock split of its outstanding shares of common stock, effective as of 12:01 a.m. Eastern Time on January 5, 2024.

January 2, 2024
·
6 min read
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

January 2, 2024
·
1 min read
Deals

XOMA Announces Stock Repurchase Program of up to $50 Million

XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized XOMA’s first stock repurchase program, which permits the Company to purchase up to $50 million of XOMA’s common stock through January 2027.

January 2, 2024
·
4 min read
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024

YolTech Therapeutic recently announced that it will present an overview of its technology and provide corporate updates on key programs at Biotech Showcase, taking place January 8-10, 2024 in San Francisco, California.

January 2, 2024
·
1 min read